https://2020hcp.com/ https://2020hcp.com/nyt-meet-virtual-reality-your-new-physical-therapist/ 2026-01-27T21:24:51-05:00 https://2020hcp.com/nemdx-inc-announces-poster-presentation-on-groundbreaking-als-research-at-neals-2024-conference/ 2024-10-23T15:14:40-04:00 https://2020hcp.com/private-equity-firm-clearhaven-partners-acquires-zixi/ 2024-07-01T20:09:27-04:00 https://2020hcp.com/xrhealth-and-amelia-virtual-care-announce-merger-creating-the-largest-xr-therapeutics-platform-in-the-world/ 2023-04-18T20:34:28-04:00 https://2020hcp.com/variantyx-secures-20m-debt-financing-to-support-precision-medicine-in-north-america-europe/ 2022-10-18T21:21:39-04:00 https://2020hcp.com/verizon-bloomberg-media-zixi-aws-test-how-5g-edge-compute-can-transform-broadcast/ 2022-02-23T12:38:11-05:00 https://2020hcp.com/technology-driven-precision-medicine-company-variantyx-secures-41-5m-in-funding/ 2022-02-14T17:54:16-05:00 https://2020hcp.com/patients-can-now-use-a-vive-flow-to-access-healthcare-in-vr/ 2022-01-13T12:55:11-05:00 https://2020hcp.com/verseau-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-for-vtx-0811-a-psgl-1-targeting-monoclonal-antibody/ 2022-01-04T19:31:08-05:00 https://2020hcp.com/xrhealth-on-demand-virtual-care-reinvented-revolutionizing-telehealth-with-vr-ar/ 2021-11-19T20:19:18-05:00 https://2020hcp.com/robert-bosch-venture-capital-joins-variantyxs-us-26-million-series-c-funding-round/ 2021-11-16T15:31:59-05:00 https://2020hcp.com/verseau-therapeutics-appoints-karen-tubridy-as-chief-development-officer/ 2021-09-07T19:50:01-04:00 https://2020hcp.com/xrhealth-receives-patent-to-measure-neck-and-shoulder-protraction-and-retraction-motions-with-ar-vr-technology-that-are-often-needed-for-rehabilitation/ 2021-07-28T22:45:29-04:00 https://2020hcp.com/xrhealth-and-reducept-offer-patients-virtual-reality-therapy-for-pain-management/ 2021-07-27T19:03:14-04:00 https://2020hcp.com/sqz-biotechnologies-strengthens-board-with-global-commercial-and-clinical-development-experience/ 2021-07-02T23:45:30-04:00 https://2020hcp.com/sqz-biotechnologies-presents-regenerative-medicine-data-demonstrating-neuron-generation-from-human-pluripotent-stem-cells-with-single-delivery-of-mrna-transcription-factor/ 2021-06-23T17:01:01-04:00 https://2020hcp.com/zixi-announces-global-rollout-of-zaas/ 2021-06-10T14:11:30-04:00 https://2020hcp.com/sqz-biotechnologies-tolerizing-antigen-carrier-tac-program-induces-antigen-specific-immune-tolerance-in-preclinical-models-demonstrating-potential-for-broad-applicability-across-autoimmune-diseases/ 2021-06-10T13:01:23-04:00 https://2020hcp.com/sqz-biotechnologies-initial-first-in-human-data-demonstrates-investigational-cell-therapy-is-safe-and-can-stimulate-immune-responses-in-certain-patients-with-advanced-or-metastatic-hpv16-tumors/ 2021-06-04T17:24:10-04:00 https://2020hcp.com/verseau-therapeutics-appoints-john-edwards-as-chief-executive-officer/ 2021-06-04T17:21:47-04:00 https://2020hcp.com/sqz-biotechnologies-to-present-first-clinical-data-at-the-american-society-of-clinical-oncology-annual-meeting-from-ongoing-phase-1-study-in-patients-with-advanced-or-metastatic-hpv-tumors/ 2021-05-22T18:44:34-04:00 https://2020hcp.com/variantyx-expands-into-prenatal-cancer-testing/ 2021-05-12T14:43:25-04:00 https://2020hcp.com/sqz-biotechnologies-reports-first-quarter-2021-financial-results-and-recent-business-highlights/ 2021-05-12T14:26:01-04:00 https://2020hcp.com/sqz-biotechnologies-to-present-new-data-on-rapid-cell-therapy-manufacturing-capabilities-and-advantages-in-cell-performance-at-asgct-2021/ 2021-05-12T14:25:09-04:00 https://2020hcp.com/sqz-biotechnologies-reports-2020-financial-results-and-recent-advancements/ 2021-03-19T13:11:19-04:00 https://2020hcp.com/news-variantyx-secures-20m-in-funding-for-whole-genome-sequencing-methodology-advanced-testing-method-that-diagnoses-genetic-disorders/ 2021-03-15T20:17:37-04:00 https://2020hcp.com/sqz-biotech-to-present-preclinical-data-on-kras-tumor-targets-and-next-generation-sqz-eapcs-at-the-american-association-for-cancer-research-aacr-2021-annual-meeting/ 2021-03-11T13:15:28-05:00 https://2020hcp.com/variantyx-licenses-ibm-technologies-that-leverage-ai-for-somatic-analysis/ 2020-12-22T15:25:01-05:00 https://2020hcp.com/sqz-biotech-lines-up-75m-ipo-for-cell-therapy-rd/ 2020-12-22T15:10:36-05:00 https://2020hcp.com/coagulo-medical-technologies-announces-6-5-million-in-financing-to-accelerate-delivery-of-disruptive-coagulation-diagnostics-platform/ 2020-12-22T15:10:07-05:00 https://2020hcp.com/tech-crunch-vr-telemedicine-platform-xrhealth-raises-7m/ 2020-11-19T23:17:34-05:00 https://2020hcp.com/enclear-therapies-announces-10m-series-a-financing/ 2020-02-20T15:57:43-05:00 https://2020hcp.com/sqz-biotech-and-askbio-announce-research-collaboration-to-create-immune-tolerization-products-for-aav-gene-therapies/ 2019-11-07T14:30:51-05:00 https://2020hcp.com/variantyx-launches-its-whole-genome-sequencing-wgs-based-in-silico-panel-program-at-national-society-of-genetic-counselors-annual-conference/ 2019-11-06T21:36:56-05:00 https://2020hcp.com/sqz-biotech-to-present-first-time-data-demonstrating-potential-of-companys-second-novel-cell-therapy-approach-in-oncology-activating-antigen-carriers-aacs/ 2019-11-05T22:30:56-05:00 https://2020hcp.com/sqz-biotech-announces-clearance-of-us-ind-application-for-first-clinical-trial/ 2019-10-22T17:26:49-04:00 https://2020hcp.com/verseau-launches-with-50-million-to-develop-first-in-class-macrophage-targeted-immunotherapies-and-appoints-george-golumbeski-as-chairman-of-the-board/ 2019-10-21T19:03:39-04:00 https://2020hcp.com/corindus-vascular-robotics-announces-definitive-agreement-to-be-acquired-by-siemens-healthineers/ 2019-08-11T16:43:18-04:00 https://2020hcp.com/hillel-bachrach-serves-as-moderator-at-mit-sloan-school-of-management-innovation-panel/ 2019-02-26T23:14:12-05:00 https://2020hcp.com/omron-healthcare-and-physiq-partner-to-transform-cardiovascular-patient-care/ 2019-02-19T22:18:05-05:00 https://2020hcp.com/sqz-biotech-expands-cell-therapy-partnership-with-roche-to-develop-antigen-presenting-cells-for-immune-oncology/ 2019-02-19T16:24:11-05:00 https://2020hcp.com/sqz-biotech-strengthens-leadership-team-with-appointment-of-chief-medical-officer/ 2019-02-19T16:20:23-05:00 https://2020hcp.com/3sbio-and-verseau-establish-global-clinical-development-collaboration-for-first-in-class-immuno-oncology-therapies/ 2019-02-19T16:12:06-05:00 https://2020hcp.com/sqz-biotech-pushes-forward-with-its-method-to-squeeze-drugs-into-cells/ 2019-01-18T18:57:31-05:00 https://2020hcp.com/new-peer-to-peer-feedback-drives-employee-engagement-to-improve-work-quality/ 2019-01-18T18:55:10-05:00 https://2020hcp.com/press-releases-news-encompass-announces-partnership-with-zixi/ 2019-01-18T18:52:17-05:00 https://2020hcp.com/vrhealth-launches-first-telehealth-vr-health-data-platform/ 2019-01-18T18:51:29-05:00 https://2020hcp.com/corindus-vascular-robotics-and-mayo-clinic-launch-vascular-robotic-program-to-research-physician-safety/ 2015-10-22T19:39:30-04:00 https://2020hcp.com/konica-minolta-acquires-viztek-to-enhance-healthcare-it-solution-capabilities/ 2015-10-22T19:38:04-04:00 https://2020hcp.com/ultraspect-to-present-xpress-suite-of-safer-imaging-solutions-at-snmmi-2015/ 2015-10-22T19:37:44-04:00 https://2020hcp.com/vbl-therapeutics-presents-positive-data-on-vb-111-in-advanced-radioactive-iodine-refractory-differentiated-thyroid-cancer-at-the-itc-2015-conference/ 2015-10-22T19:36:19-04:00 https://2020hcp.com/2020-hcp-investment-goes-public-vbl-therapeutics-announces-closing-of-initial-public-offering/ 2014-10-09T12:53:46-04:00 https://2020hcp.com/massachusetts-life-sciences-center-announces-new-appointee-to-board-of-directors-and-four-new-members-of-scientific-advisory-board/ 2014-05-30T12:54:33-04:00 https://2020hcp.com/879/ 2014-05-28T16:59:27-04:00 https://2020hcp.com/2020-imaging-welcomes-podiatrys-first-dedicated-direct-radiography-dr-system/ 2014-04-14T18:35:25-04:00 https://2020hcp.com/investment-in-corindus-inc/ 2014-04-14T18:34:43-04:00